Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,331.20
(
-0.09%
)
Dow Jones
49,526.17
(
0.00%
)
Brent Oil
106.17
(
-1.21%
)
Bitcoin
77,368.61
(
-0.05%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: DewDiligence post# 164597

Sunday, 07/28/2013 6:50:48 PM

Sunday, July 28, 2013 6:50:48 PM

Post# of 257580
[ABBV] Considering the difficult regulatory environment facing developers working within the HCV nucleotide analog class the FDA could be looking to the ABBV combo as a SOC proxy towards future GT1 development. The GILD combo clearly will become the next SOC in GT2.



Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today